Is Osteoporosis Disease Management Cost Effective?
- Published in:
- Current Osteoporosis Reports, 2010, v. 8, n. 1, p. 49, doi. 10.1007/s11914-010-0009-0
- By:
- Publication type:
- Article
Works matching IS 15441873 AND DT 2010 AND VI 8 AND IP 1
Results: 9
1
2
The Role of Microbial Biofilms in Osteonecrosis of the Jaw Associated with Bisphosphonate Therapy.
- Published in:
- Current Osteoporosis Reports, 2010, v. 8, n. 1, p. 40, doi. 10.1007/s11914-010-0008-1
- By:
- Publication type:
- Article
3
Anabolic Therapies.
- Published in:
- Current Osteoporosis Reports, 2010, v. 8, n. 1, p. 23, doi. 10.1007/s11914-010-0005-4
- By:
- Publication type:
- Article
4
Denosumab Reduces the Incidence of New Vertebral Fractures in Men With Prostate Cancer.
- Published in:
- Current Osteoporosis Reports, 2010, v. 8, n. 1, p. 1, doi. 10.1007/s11914-010-0001-8
- By:
- Publication type:
- Article
5
Benefits and Limitations of Bone Mineral Density and Bone Turnover Markers to Monitor Patients Treated for Osteoporosis.
- Published in:
- Current Osteoporosis Reports, 2010, v. 8, n. 1, p. 15, doi. 10.1007/s11914-010-0004-5
- By:
- Publication type:
- Article
6
Glucocorticoid-Induced Osteoporosis: Management Update.
- Published in:
- Current Osteoporosis Reports, 2010, v. 8, n. 1, p. 10, doi. 10.1007/s11914-010-0003-6
- By:
- Publication type:
- Article
7
Atypical Subtrochanteric and Femoral Shaft Fractures and Possible Association with Bisphosphonates.
- Published in:
- Current Osteoporosis Reports, 2010, v. 8, n. 1, p. 34, doi. 10.1007/s11914-010-0007-2
- By:
- Publication type:
- Article
8
Orthopedic Uses of Teriparatide.
- Published in:
- Current Osteoporosis Reports, 2010, v. 8, n. 1, p. 28, doi. 10.1007/s11914-010-0006-3
- By:
- Publication type:
- Article
9
Intravenous Zoledronic Acid: What Are the Indications for Male Osteoporosis?
- Published in:
- Current Osteoporosis Reports, 2010, v. 8, n. 1, p. 4, doi. 10.1007/s11914-010-0002-7
- By:
- Publication type:
- Article